Common infections will kill millions if drug resistance through misuse of antibiotics is not curbed, says England’s ex-chief medical officer.

It kills millions every year, with a potential impact in the near future that could dwarf that of the Covid-19 pandemic but AMR, or antimicrobial resistance, remains a little-known problem outside specialist circles.

The AMR Action Fund announced that one of its portfolio companies, UTILITY Therapeutics, Ltd., received approval from the U.S. Food and Drug Administration (FDA) for the antibiotic PIVYA™ (pivmecillinam) for the treatment of uncomplicated UTIs (uUTI).

A recent appeals court ruling in California has posed a burning question for regulators, the life sciences industry, and patients. Who should be in charge of developing safe, life-saving medications: scientific experts and the FDA, or judges?   There’s a troubling answer — and disastrous implications — in the ruling, which, if it stands, would…

In Japan’s Kanagawa Prefecture, just south of Tokyo, one in four residents is older than sixty-five — and that’s the youngest the population will be for a long while to come. Policy makers around the globe would do well to take notes from their response to the aging megatrend.